Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

MS drug rituximab tested for brain and hand benefits in advanced patients

NCT ID NCT06599307

First seen Mar 30, 2026 · Last updated May 23, 2026 · Updated 7 times

Summary

This study tests whether the drug rituximab can improve memory, thinking speed, and hand coordination in people with advanced secondary progressive multiple sclerosis (SPMS). About 46 participants with high disability will receive either rituximab or a placebo for one year. Researchers will measure changes in cognitive tests, hand dexterity, and quality of life to see if the drug offers meaningful benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kasr Alainy Multiple Sclerosis Unit (KAMSU), Cairo University hospitals.

    RECRUITING

    Giza, Giza Governorate, Egypt

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.